Panelists discuss how treatment strategies differ between transplant-eligible and transplant-ineligible multiple myeloma patients, with transplant eligibility determined by functional status rather ...
Governors Brad Little of Idaho, Mark Gordon of Wyoming, Michelle Lujan Grisham of New Mexico, Spencer Cox of Utah, Josh Green of Hawaii, Jared Polis of Colorado and Joe Lombardo of Nevada stand ...
The ordinary graphite in pencil lead is proving to be surprisingly multifaceted at the microscale. In a study published in the journal Nature, MIT researchers report that a certain microscopic ...
How-To Geek on MSN
Sparklines in Excel: The fastest way to visualize data without charts
Sparklines turn spreadsheet rows into instant visual trends without building traditional Excel charts.
How-To Geek on MSN
Your Excel regression is probably a mess—here's how Python fixes it
Uncover the hidden pitfalls of Excel regression and learn why Python is the key to unlocking clean, efficient data analysis.
The efficacy of teclistamab, a bispecific antibody targeting B-cell maturation antigen and CD3, as early-line monotherapy in relapsed or refractory multiple myeloma is unclear. We randomly assigned ...
Security lines stretched for hours at several major U.S. airports Sunday, March 8, as a partial government shutdown and the start of spring break travel collided, leaving some passengers scrambling to ...
Treatment costs for multiple myeloma are higher than those for many other types of cancer. One reason for this is that multiple myeloma is a chronic condition that may require treatment for years. If ...
A proposed combination of Johnson & Johnson’s multiple myeloma bispecific Tecvayli has turned up positive trial data that could put some pressure on CAR T-cell therapies, including the company’s own ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results